Non-Daily Cigarette Smokers: Mortality Risks in the U.S.


Journal

American journal of preventive medicine
ISSN: 1873-2607
Titre abrégé: Am J Prev Med
Pays: Netherlands
ID NLM: 8704773

Informations de publication

Date de publication:
01 2019
Historique:
received: 05 04 2018
revised: 20 05 2018
accepted: 20 06 2018
pubmed: 21 11 2018
medline: 26 3 2020
entrez: 21 11 2018
Statut: ppublish

Résumé

Worldwide, an estimated 189 million adults smoke tobacco "occasionally" but not every day. Yet few studies have examined the health risks of non-daily smoking. Data from the 1991, 1992, and 1995 U.S. National Health Interview Surveys, a nationally representative sample of 70,913 U.S. adults (aged 18-95 years) were pooled. Hazard ratios and 95% CIs for death through 2011 were estimated from Cox proportional hazards regression using age as the underlying time metric and stratified by 5-year birth cohorts in 2017. Non-daily smokers reported smoking a median of 15 days and 50 cigarettes per month in contrast to daily smokers who smoked a median of 600 cigarettes per month. Compared with never smokers, lifelong nondaily smokers who had never smoked daily had a 72% higher mortality risk (95% CI=1.36, 2.18): higher risks were observed for cancer, heart disease, and respiratory disease mortalities. Higher mortality risks were observed among lifelong non-daily smokers who reported 11-30 (hazard ratio=1.34, 95% CI=0.81, 2.20); 31-60 (hazard ratio=2.02, 95% CI=1.17, 3.29); and >60 cigarettes per month (hazard ratio=1.74, 95% CI=1.12, 2.72) than never smokers. Median life-expectancy was about 5 years shorter for lifelong non-daily smokers than never smokers. As expected, daily smokers had even higher mortality risks (hazard ratio=2.50, 95% CI=2.35, 2.66) and shorter survival (10 years less). Although the mortality risks of non-daily smokers are lower than daily smokers, they are still substantial. Policies should be specifically directed at this growing group of smokers.

Identifiants

pubmed: 30454906
pii: S0749-3797(18)32098-1
doi: 10.1016/j.amepre.2018.06.025
pmc: PMC7477821
mid: NIHMS1625442
pii:
doi:

Types de publication

Journal Article Research Support, N.I.H., Intramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

27-37

Subventions

Organisme : Intramural NIH HHS
ID : Z99 CA999999
Pays : United States

Informations de copyright

Published by Elsevier Inc.

Références

Pediatrics. 2015 Feb;135(2):246-54
pubmed: 25583910
Int J Cancer. 2018 Jan 15;142(2):271-280
pubmed: 28929489
Nicotine Tob Res. 2000 May;2(2):133-9
pubmed: 11072451
MMWR Morb Mortal Wkly Rep. 2016 Nov 11;65(44):1205-1211
pubmed: 27832052
Cancer Res. 2003 Oct 1;63(19):6556-62
pubmed: 14559851
BMJ Open. 2017 Dec 28;7(12):e019107
pubmed: 29288187
Circulation. 2010 Apr 6;121(13):1518-22
pubmed: 20368531
Nicotine Tob Res. 2009 Feb;11(2):122-5
pubmed: 19246630
Nicotine Tob Res. 2008 Feb;10(2):287-99
pubmed: 18236293
JAMA Intern Med. 2017 Jan 1;177(1):87-95
pubmed: 27918784
Cancer Epidemiol Biomarkers Prev. 2017 Feb;26(2):228-239
pubmed: 27760782
J Intern Med. 1992 Apr;231(4):357-62
pubmed: 1588259
Cancer Epidemiol Biomarkers Prev. 2014 Jul;23(7):1264-72
pubmed: 24740202
BMJ. 2004 Jun 26;328(7455):1519
pubmed: 15213107
Am J Public Health. 1989 Feb;79(2):200-2
pubmed: 2913842
J Epidemiol Community Health (1978). 1978 Dec;32(4):303-13
pubmed: 744822
MMWR Morb Mortal Wkly Rep. 1994 May 20;43(19):342-6
pubmed: 8177192
Cancer Causes Control. 2006 Dec;17(10):1305-9
pubmed: 17111263
Tob Control. 2005 Oct;14(5):315-20
pubmed: 16183982
JAMA Intern Med. 2018 Apr 1;178(4):469-476
pubmed: 29459935
Am J Epidemiol. 2001 Apr 15;153(8):807-14
pubmed: 11296155
Lancet. 2013 Jan 12;381(9861):133-41
pubmed: 23107252
Cancer Epidemiol Biomarkers Prev. 2006 Mar;15(3):517-23
pubmed: 16537710
BMJ. 2018 Jan 24;360:j5855
pubmed: 29367388
J Epidemiol Community Health. 2002 Sep;56(9):702-6
pubmed: 12177089
N Engl J Med. 2013 Jan 24;368(4):341-50
pubmed: 23343063
N Engl J Med. 2006 Jan 26;354(4):333-42
pubmed: 16436765
Natl Vital Stat Rep. 2001 May 18;49(2):1-32
pubmed: 11381674

Auteurs

Maki Inoue-Choi (M)

Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, Maryland. Electronic address: maki.inoue-choi@nih.gov.

Timothy S McNeel (TS)

Information Management Services, Inc., Calverton, Maryland.

Patricia Hartge (P)

Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, Maryland.

Neil E Caporaso (NE)

Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, Maryland.

Barry I Graubard (BI)

Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, Maryland.

Neal D Freedman (ND)

Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, Maryland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH